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For various at C(3)-chiral 1,4-benzodiazepin-2-ones rate deter-
minations of racemisation (ka.- for C(3)-0CH3 derivative ( + )-1), 
degenerate nucleophilic exchange (k
0
- for rac. 1 and rac. 2), and 
solvolysis (k
5
- for C(3)-hemisuccinyl derivative 4) have been per-
formed. These investigations revealed; (a) retention of .configu-
ration during methanolysis of ( + )-3, (b) slow racemisation of 
( + )-1 during solvolytic degenerate nucleophilic substitution (kefko. -
- 4), (c} no participation of SNl retentive reaction, possible via 
intramolecular transfer of the methoxy group within intermediary 
compounds 4-6, (d) thermodi:namic parameters for racemisation 
of ( + )-1 between 20-40 °c; liH"" = 18.0 ± 0.8 kcal/moll**, liS"" = 
= - 7.2 ± 2.5 e. u.*** Mechanistic scheme is offered which accounts 
for all experimental results. The effect of the electrocyclic equili-
brium on the electronic structure of N(4) protonated benzodiazepines, 
and its possible consequences for their mechanisms of biological 
activity on the central nervous system (CNS), have briefly been 
discussed. 
INTRODUCTION 
Recently2•3 we discussed mechanisms likely to be involved in acid-catalysed 
solvolytic racemisation of various 3-substituted 1,4-benzodiazepin-2-ones at 
the C(3)-chiral centre. We now wish to present further investigations of acid-
-catalysed solvolysis which led to some speculation on the fluctuating electronic 
structures arising upon protonation at N(4). Such structures may hold implicat-
ions worth considering in discussion of biological effects produced by various 
1, 4-benzodiazepin-2-one derivatives. 
The three different mechanisms proposed by us2 as potential routes of 
racemisation in acid-catalysed solvolysis were (a) C(3)-H/D exchange, (b) ring-
-chain tautomerism (for 3-hydroxy derivatives), and (c) the identity reaction, 
i. e. degenerate nucleophilic substitution (for 3-alkoxy derivatives). Recent 
reports by other authors4- 6, however, suggest that bimolecular nucleophilic sub-
stitutions might occur with retention of configuration, taking their way over 
an intermediate with a five-coordinated carbon atom. We thought that this 
may be the way followed by acid-catalysed methanolysis of the hemisuccinyl 
** 1 kcal = 4.184 x 1Q3 J 
*** e. u. = 4.184 J K-1 mo1-1 
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ester ( + )-3 which was recognized to occur with retention of configuration7, a 
result we were able to confirm2• 
We found previously that acid-catalysed solvolyses of several 3-(quat. am-
monio)-substituted 1,4-benzodiazepin-2-ones result in racemisation by a me-
chanism of HID exchange2 • The same was found with one (3R)-phenyl deri-
vative8, accompanied by a rapid loss of optical activity. The question of whether 
racemisation of 3-hydroxy derivatives partly occurs by the mechanism of ring-
-chain tautomerism as assumed2 will be the subject of a future paper. Presently 
we shall describe a study of kinetics and mechanism of degenerate exchange 
suggested2 for acid-catalysed solvolysis in the 3-alkoxy series of 1,4-benzo-
diazepin-2-ones. In this study we used the methoxy derivatives 1-2 and 7-8, 
and additionally the 3- hemisuccinyl derivatives 3-6 (intended to represent the 
class of 3-acyloxy derivatives). A survey of these compounds is given in general 
formula below, details 'about their preparations are given in the Experimental. 
R R1 
1 H CH3 R 
I 0 2. CH 3 CH3 
")<~~ l H COCHfHfOOH 
Cl i H COCHf H2COOCH3 




1 H co3 
]. CH3 CD3 
RESULTS AND DISCUSSION 
The replacement of a C(3)-alkoxy group effected by acid-catalysed alcohol-
ysis was studied kinetically in considerable detail so as to obtain a better 
insight into the mechanism of degenerate nucleophilic substitution. The time 
course of substitution was followed by two techniques : NMR technique was 
used with racemic 1 and 2, and polarimetric technique with the dextrorotatory 
enantiomer of the former, ( + )-1. The results of rate determinations are sum-
marized in Tables I (polarimetric) and II-IV (NMR). 
The following results were derived from polarimetrically and NMR deter-
mined rate constants ka, and ke, respectively. 
(a) Thermodynamic activation parameters were calCulated on the basis of 
temperature dependence of k (runs no. 12-18 in Table I). The values obtained, 
t..H"" = 18.0± 0.8 kcal/mol and t..S"" = - 7.2 ± 2.5 e. u . per mol, are such as 
to leave open the question of molecularity for the rate-determining step9• 
(b) In experiments with compounds 1 and 2 the rate constants ke obtained 
at 35 °c (runs no. 4 in Table III and Table IV) could be compared with k a's 
obtained for ( + )-1 under nearly same CH+/Cs ratio and temperatures (runs no. 
3, 16 and 17 in Table I) . They give kel ka. ratios of 3.40, 4.62 and 3.29, respectively. 
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TABLE I 










I t/;0c I k x 104/s 
28.0 1.05 ±0.04 































CH+/CB t/°C kX 104/s 
6.82 44.5 10.30 ±0.19 
,, ,, 10.26 ±0.22 
3.87 21.0 0.86±0.10 
23.0 1.43 ±0.02 
26.5 1.95 ± 0.08 
30.5 2.90±0.04 
33.0 3.81 ±0.05 
36.0 5.35±0.09 
39.5 7.02±0.12 
Rate Constants for Solvolysis 4--+ 1 (in CD30D/DC! at 35 ± 0.1 °C) 
Run I Co+/ CB k,X 103/s no. - M/M-
1 0.245 0.59±0.05 
2 0.461 0.71±0.04 
3 0.622 1.05±0.06 
4 0.893 1.42 ± 0.09 
5 1.755 3.06±0.15 
6 2.644 5.11±0.18 
TABLE III 
Rate Constants for the Exchange Reaction 2--+ 8 (in CD30D/DC! at 34.5 ± 0.2 °C) 
·-----
Run I Co+/cB keX 103/s-1 no. M/M 
1 0.791 0.69±0.08 
2 1.293 0.71±0.06 
3 1.945 1.23 ±0.11 
4 3.889 1.76±0.18 
5 7.718 3.89±0.28 
configuration pro five degenerate exchanges in ( + )-1 properly reflects relatively 
high stereoselectivity of this process. 
(c) As nearly the same values of ke were obtained with compounds 1 and 
2, the influence of N(l)-substitution upon the rate of solvolysis can only be 
very weak. 
(d) With compound 4 somewhat larger ke values (Table II) were found 
than with 1 and 2. This obviously means that acyloxy is a better leaving group 
than alkoxy. In experiments with 4 the NMR recordings showed no shift from 
the singlet at 3.68 ppm characteristic of ... COOCH3-protons to that at 3.63 ppm 
characteristic of .. . OCH3-protons, but instead a singlet appeared at 2.63 ppm 
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TABLE IV 
Rate Constants for the Exchange Reaction 1 -+ 7 (in CD30D/DCL at 35.0 ± 0.1 °C) 




2 0.722 0.54±0.06 
3 0.722 0.53±0.04 
4 0.806 0.58±0.08 
5 0.911 0.65±0.03 
6 0.924 0.67±0.07 
7 0.924 0.67±0.06 
8 1.027 0.72±0.04 
(4H). This singlet is characteristic of protons in equivalent methylene groups, 
which indicates that symmetric dimethyl succinate was formed during solvolysis. 
Therefore the conversion of 4 to 1 could not include intramolecular transfer of 
OCH3 to C(3)-position, but must be solely the result of methoxy transfer from 
the solvent. 
(e) Compounds 5 and 6 were subjected to acid-catalysed methanolysis, and 
samples of the reaction mixture taken at intervals were quenched in aqueous 
acetate which was followed by quantitative extraction and isolation of the 
product. Values of NMR-signal ratios for H and OCH3 bound to C(3) in the 
product show that in this instance, too, OCH3 could only have entered by 
transfer from the solvent. No exchange of H for OCD3 occured in similar 
experiments where formation of 7 and 8 failed to occur. 
As mentioned in the Introduction, we once regarded the r etention of con-
figuration after solvolytic conversion of ( + )-3 to ( + )-1 as being a consequence 
of an intramolecular SN-type reaction taking place without configuration change. 
We assumed that ( + )-3 first undergoes an acid-catalysed esterification to give 
( + )-4, whereupon the methylated acyloxy group pseudorotates from axial 
position, on pentacoordination at C(3), with subsequent intramolecular transfer 
of the methoxy terminal and exit of the acyloxy group (Scheme 1). But the 
results presented under d and e invalidate this sequence. Furthermore, at the 
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experimental evidence against a participation of pentacoordinated carbon in 
the configuration-retaining SN2 mechanism. On the other hand, a monomolecular 
nucleophilic substitution mechanism should be precluded by the positive charge 
on the protonated N(4)-atom. It is noteworthy, however, that retentions observed 
during solvolysis of carbocyclic seven membered analogues of benzodiazepines, 
i. e. C(9)-substituted tribenzocycloheptatrienes, have been explained by a con-
figuration retaining SNl mechanism12,13• We think that the retention of con-
figuration in acid-catalysed methanolysis of ( + )-3 is due to two nucleophilic 
steps each associated with inversion. We also think that this mechanism involv-
ing two inversion steps applies to the acid-catalysed solvolysis of ( + )-1 after 
which configuration was largely retained, contrarily to an expected racemisation 
by degenerate exchange. 
Further details of the mechanism remained unclarified at first. However, 
we succeeded in isolating trace amounts of a by-product formed in solvolysis 
of ( + )-3 which helped to better understand the reaction sequence. Spectroscopic 
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structure was confirmed by oxidation which gave a product of known structure, 
namely the acid 13. A mechanism for the acid-catalysed solvolytic conversion 
of ( + )-3 to ( +)-1 based on these findings is depicted in Scheme 2. In this scheme 
both 11 and ( + )-1 appear as products stemming from one highly strained inter-
mediate, A. The formation of this intermediate is associated with the first in-
version which takes place after N(4)-protonation of ( + )- 3 and equilibration with 
a valence tautomer ( + )-3'. Intermediate A contains two three-membered rings, 
oxirane and aziridine, readily opened by solvolysis. An opening of the aziridine 
ring _ (pathway 1) should give compound B, and is associated with the second 
inversion. Therefore B returns to the configuration of the starting compound, 
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( + )-3. The opening of the oxirane ring (pathway 2) results in the formation of 
C which also should have the configuration of the starting compound. Both 
the oxirane14 and aziridine15,16 ring systems can, however, be opened with 
retention of configuration when the reagent attacks from the front side. This 
mechanism of ring opening might account for the slow racemisation of ( + )-1 , 
about 800/o stereoselectivity found in the solvolytic identity reaction.* 
Compound 11 is formed as a result of two consecutive pericyclic reactions: 
(1) electrocyclic 6rr-disrotatory17 ring closure, and (2) 1,2-suprafacial proton 
shift1s. The electrocyclic equilibrium (valence tautomerisation) ( + )-3 ~ ( + )-3' 
seems to be induced by N(4)-protonation, as the N(4)-atom should exhibit much 
stronger electron-donating ability (basicity) within an aziridine ring in the 
( + )-3' form, than in ( +;)-3. This offers a new aspect to MO properties in 3', a 
type of structure regarded previously as an aza-polymethine form of 1,4-benzodi-
azepines19. Namely several structures associated with central tranquilizing 
activity (see Scheme 3) share a characteristic electronic system. This group of 
compounds includes 2-oxy and 2-deoxy-1,4-benzodiazepines as a major sub-
group of centrally acting tranquilizing agents20 . Isomeric 1-oxy-2,4-benzodiaze-
pines21, and 2-oxy-quinazolines22 are further representatives of compounds con-
taining the lOrr-electronic system. We suppose that characteristic HOMO-LUMO 
energy states common to all these structures may play an important role in 
biological actions at the submolecular, i. e. electronic level. The influence of 
* One of the referees still pointed out that SN 1-type mechanism could be 
opperative. It includes intramolecular proton transfer form the N(4)-atom to the 
ester carbonyl group, leading to a flat boat (chiral) conformation of the carbocation 
(see scheme) 
Then k efka. - 4 could mean that stereoselective trapping with methanol, i. e. from 
the same side of the boat from which the leaving group has gone out, occurs 4 times 
faster than the ring inversion. We abandoned previously this possibility after consi-
deration of the pronounced negative entropy of the solvolysis, and because of the 
requirement for nitrogen N(4) deprotonation. Namely, its basicity should move along 
the electrocyclic equilibrium ranging from pKa -3 - in benzodiazepines - to pKa -10 
in aziridines, while an excess of the »free« protons in solution remains. We now 
would like, however, to accept this possibility, and to emphasize that NMR method 
for kinetic measurements precludes determination of a possible kinetic isotope effect 
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substituents in 5- or 7-position (X and Ph in the Scheme 3) on these energy 
levels may also serve to explain the marked alterations in central activity 
observed upon substitution in these position of several benzodiazepines23 
Theoretical and experimental work further elaborating on these ideas is being 
continued in our laboratories. 
EXPERIMENTAL 
General. - All m. p.'s were determined on a Kofler microheating stage (Boetius), 
uncorrected values are given. 
Samples used for spectrometry, polarimetry and elemental microanalyses were 
previously dried 2 h at room temperature under reduced pressure (0.01 mm Hg). 
Apparatus. - Measurements of optical rotation were made at constant tempe~ 
rature using an NPL Model M3D or a Perkin-Elmer Model 141 polarimeter, using 
double-walled optical cells connected to a VEB type U6 thermostat. 
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NMR spectra were recorded with a Varian T-60 spectrometer. The same in-
strument was used for peak integrations at 35 ± 0.1 °c. A Perkin-Elmer M 257 NMR 
spectrometer was used for peak integrations at 34.5 ± 0.2 °C. 
Titrations carried out to determine the acid content of solvents used in kinetic 
experiments were recorded using an automatic buret (Mod. ABU13) connected to a 
Titrigraph SBR-2c unit (Radiometer, Copenhagen, Denmark) . 
Chromatograms. - TL chromatograms were obtained on silica gel Fertigplatten 
F-257 (E. Merck, Darmstadt, W. Ger.). Column chromatography was run with silica 
gel (particle size 0.05-2 mm) from Merck. Fractions were separated with an LKB 
7000 automatic fraction collector. 
Syntheses 
Compounds 1, 2, 7 and 8 were prepared on the basis of published directions24 , 
using methanol-d4 instead of CH30H in preparing 7 and 8. Racemic 325 and its 
dextrorotatory enantiomer ( + )-325, as well as ( + )-1 2n were prepared by methods 
described in the patent literature. 
Monomethyl-d3-succinate (9). - Starting from 4.0 g (40 mmol) of succm1c an-
hydride (Fluka : purum, m. p. 119-121 °C) and 2.50 ml of methanol-d4 (Stohler, Isotope 
Chem.,: 99.5°/o deuterated) the hemiester 9 was prepared by a known procedure27• 
NMR-monitoring indicated a fast formation of 9, as the singlet at 3.01 ppm (CH2C0)20 
disappeared completely within 10-15 min. The warm reaction mixture was allowed 
to solidify in a mortar. The solid was ground, and the resulting crystalline powder 
was transferred to a drying vessel over P 20 5, where it was kept overnight at 0.1 mm 
Hg. Recrystallization from carbon disulfide-ether gave pure 9, m. p. 51-53 °C. NMR 
(CDC13): 2.70 (broad s, 4H). 
Anal. C5H4D40 4 (136.15) calc'd.: C 44.11, H 8.88°/o 
found: C 44.22, H 8.49°/o 
Silver Salt of Monomethyl-d3 Succinate (10). - To a solution of the monomethyl 
ester 9 (1.36 g, 10.0 mmol) in redistilled C02-free water (10 ml), analytically pure 
sodium hydrogencarbonate (1.06 g, 10.0 mmol) was gradually added. The obtained 
solution was passed through a fluted filter which was subsequently rinsed with three 
3-ml portions of water. Under vigorous stirring of combined filtrate and rinsings, a 
solution of silver nitrate (1.70 g, 10.0 mmol) in water (10 ml) was gradually added, 
which resulted in precipitation of 10. The precipitate was collected on a filter and 
washed, first with water, then with methanol, and finally with ether (taking three 
portions of 5 ml of each washing liquid). After drying under reduced pressure, 1.79 g 
(74.80/o) of 10 was obtained in an analytically pure form, m. p. 230-235 °c (dee.) . 
Anal. C5H4D304 (241.995) calc'd.: C 24.82, H 4.17-0/o 
found: C 24.67, H 4.02°/o 
7-Chloro-1,3-dihydro-1-methyl-3-(methyl-d3 succinyl)oxy-5-phenyl-1,4-benzodi-
azepin-2-one (6). - A solution of 3,7-dichloro-1,3-dihydro-l-methyl-5-phenyl-l,4-ben-
zodiazepine-2-one (1.85 g, 5.81 mmol; synthesised as in ref. 28) was prepared with 
dry benzene (25 ml) and cooled in an ice bath with magnetic stirring, while gradually 
adding 1.29 g (5.35 mmol) of the silver salt 10. Stirring was continued at room tem-
perature for 22 h, carefully protecting the mixture from light and moisture. Th.e 
precipitate formed at the end of this period was filtered off with suction using cellite 
as a filter-aid. The filtrate was evaporated in vacuo, and the oily residue was trans-
ferred to a chomatographic column (150 ml of silica gel) . Elution was carried out with 
methylene chloride-acetone (95/5), and 10-ml fractions were collected. Crude 6, 1.79 g 
(760/o), was obtained from fractions 39-76. The later fractions 101-142 yielded 0.195 g 
of a side-product, 3-hydroxy- 1,4- benzodiazepin-2-one.After recrystallizing the main 
product from methylene chloride-acetone (95/5), pure 6 was obtained, m. p. 63-65 °C. 
NMR (CDC13), ppm: 2.72 (t, J = 4.2 Hz, 2H), 3.49 (s, 3H), 5.99 (s, lH), 7.2-7.8 (m, 8H). 
Ir (KBr) cm-1 : 1740, 1700, 1610, 1480, 1166, 830, 690. 
Anal. C21H;GDaClN205 (417.87) calc'd.: C 60.36, H 5.31, N 6.700/o 
found: C 60.53, H 5.47, N 7.590/o 
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7-Chloro-1,3-dihydro-3-(methyl-d3 succinyl)oxy-5 -phenyl-1,4-benzodiazepin-2-one 
(5). - The procedure described in preparation of 6 was applied to 3,7-dichloro-1 ,3-
-dihydro-5-phenyl-1,4-benzodiazepin-2-one26 (1.63 g, 5.36 mmol) and to the silver salt 
10 (2.13 g, 7.00 mmol) in dry benzene (30 ml). However, because of limited solubility 
of the dichloro derivative in benzene 48 h were required to achive a high yield of 
5 (as found by TLC-monitoring, eluant methylene chloride-acetone 90/10). Separation 
by column chromatography (150 g of silica gel) using the same eluant and collecting 
10-ml fractions gave 2.23 g (820/o) of crude 5 from fractions 74--118. Recrystallization 
from cyclohexane yielded pure 5, m. p. 86-88 °c. NMR (CDCh), ppm: 2.74 (t, J = 
= 4.8 H z, 2H), 6.00 (s, lH) , 7.1-7.8 (m, 8H), 10.1 (s, lH). 
Anal. C2oH14D3ClN205 (403.84) calc'd.: C 59.49, H 4.99, N 6.930/o 
found: C 59.51, H 4.75, N 7.290/o 
7-Chloro -1 ,3-dihydro-3-(methylsuccinyl)oxo-5-phenyl-1,4-benzodiazepin-2-one ( 4). 
To prepare 4, 3,7-dichloro-1,3-dihydro-5-phenyl-1,4-benzodiazepin-2-one28 (3.04 g, 
10 mmol) was reacted with silv~r salt of monomethyl succinate (2.65 g, 11 mmol) 
which was prepared by the same procedure as the trideuterated analogue 10 [m. p. of 
C5H7Ag04 : 242-246 °c (dee.)]. After carrying out the steps described in preparation 
of 5, 3.4 g (800/o of crude 4 was obtained which, on recrystallization from chloroform-
-diisopropyl ether, gave. a pure product melting at 61-62 11C. NMR (CDCl3), ppm: 
2.72 (t, J = 4.2 Hz, 2H), 2.93 (t, J = 4.2 Hz, 2H), 3.68 (s, 3H), 5.94 (s, lH), 7.1-7.8 (m, 8H), 
10.2 (broad s, lH). 
Anal. C21H 19ClN20 5 (424.85) calc'd.: C 59.37, H 4.51, N 8.3•Wo 
found: C 59.66, H 4.38, N 8.07°/o 
Methyl 6-Chloro-1,2-dihydro-4-phenylquinazoline-2-carboxylate (11). - Compound 
1 (1.0 g, 3.32 mmol) was dissolved in 50/o, methanolic hydrogen chloride (20 ml). The 
solution was heated to 40 °c and maintained at this temperature for 4 h. The 
solvent was than evaporated in vacuo leaving a red crystalline material. This residue 
was slurried in satd. sodium hydrogencarbonate, and extracted with ether (3 X 20 ml). 
The ethereal extract was dried (Na2S04) , freed of solvent by evaporation, and the 
residual material was recrystallized from ether-cyclohexane to give the pure product. 
After drying over P 20 5 under reduced pressure (0.01 mm Hg) and careful protection 
from light (otherwise discoloration to intense red-brown occurs) the m. p. was 106-
107 1>C. NMR (CDC13), ppm: 3.82 (s, 3H), 4.89 (broad s, lH), 5.47 (s, lH), 6.66 (dd, 
J = 8.0 and 2.0 Hz, respectively, lH), 7.0- 7.7 (m, 7H). Ir (KBr), cm-1 : 3380, 2960, 1717, 
1620, 1600, 1580, 1565, 1470, 1330, 895, 825, 811, 700. 
Anal. C16H 13C1N20 2 (300.71) calc'd: C 63.89, H 4.35, N 9.320/o 
found: C 63.61, H 4.09, N 9.170/o 
Methyl 6-chloro-4- phenylquinazoline-2-carboxylate (12). - To a solution of 11 
(0.55 g, 1.83 mmol) in methanol (10 ml) 0.1 g of 100/o Pd/C catalyst was added, and 
magnetic stirring was started. A stream of air was bubbled through the stirred 
solution during 4 h. At the end of this period the catalyst was removed by filtration, 
and the solvent by evaporation. The residual solid was recrystallized from ether-light 
petroleum to give 0.46 g (83.5°/o) of pure 12, m. p. 132-134 °c. NMR (CDC13) , ppm: 4.12 
(s , 3H), 7.6-8.3 (m, 8H). 
Anal. C1r.H11ClN202 (298.69) calc'd.: C 64.33, H 3.71, N 9.380/o 
found: C 64.41, H 3.59, N 9.09°/o 
Pure 12 (0.2 g) was hydrolysed in 10°/o methanolic potassium hydroxide (5 ml) 
one hour at room temperature. The mixture was then neutralised with aqueous sodium 
acetate, and part of the solvent was evaporated. The remaining solution was extracted 
with ether (3 X 10 ml), and crude 6-chloro-4-phenylquinazoline-2-carboxylic acid (13) 
was obtained from the extract. Recrystallization from ether gave a purified product. 
m. p. 210-211 °c in good agreement with the literature29 value 212.5-213.5 °c. 
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Kinetics 
Polarimetry. - Racemisation rates were measured by weighing (50.0 ± 0.1)-mg 
samples of ( + )-1 ([a] 0 = + 197°, c = 0.80 in methanol) into 5.0 ml volumetric flasks, 
filling up to mark with methanolic hydrogen chloride and mixing to completely dis-
solve the sample. The time count was begun from this point on, but the follow-up 
of rotation values was started 5-6 min later, after the clear solution had been 
transferred to a 1-dm double-walled thermostated cell placed in the polarimeter. 
Minimum of 40 points has been used for rate calculations. 
NMR spectrometry. - To measure rates of H/D exchange, racemic 1, 2 and 3 
were dissolved in methanolic-d4 hydrogen chloride (DCl contents determined by 
automatic microtitration) and transfered immediately to the NMR tube. The tim~ 
course of exchange was followed up at 1.5 to 2-min intervals integrating relevant 
NMR peaks. The follow-up was extended over 5-7 half-times, and minimum of 
20 points has been obtained. 
Side-reactions, as detected by TLC of samples of reaction mixtures taken at 
intervals, were only taken into account when at least 100/o of starting material was 
diverted into a side-product. 
Calculations of pseudo-first order rate constants, and of thermodynamic magni-
tudes, were carried out by computer using a non-linear least-squares program based 
on a program published in the Los Alamos Scientific Laboratory Report LA 2367 
and its Addenda. 
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SAZETAK 
Hiralni 1,4-benzodiazepin. X. Dalja istrazivanja konfiguracione stabilnosti hiralnog 
centra C(3) 
V. Sunjic, A . Lisini, T. Kovac, B. Belin, F. Kajfez i L. Klasinc 
Za razlicite na C(3) hiralne 1,4-benzodiazepin-2-one odredene su brzina racemi-
zaci je (K .. - za C(3)-0CH3 derivat ( + )-1), brzina degenerirane nukleofilne zamjene 
(ke- za rac. 1 i rac. 2), te brzina solvoliza (k5 - za C(3)-hemisukcinil-derivat 4). Ova 
istrazivanja su pokazala; (a) retenciju konfiguracije tokom metanolize spoja ( + )-3, 
(b) polaganu racemizaciju ( + )-1 tokom solvolitske degenerirane supstitucije 
(kefk .. - 4), (c) da retenciju ne uzrokuje SNl-reakcija, moguca intramolekularnim 
premfestanjem metoksi skupine unutar intermedijera 4-6, (d) slijedece termodinamske 
parametre za racemizaciju (+)-1 (izmedu 20-40°C); !'>. H"" = 18.0 ± 0.8 kcal/mol, 
!'>. s;e = -7.2 ± 2.5 e. u. Dana je mehanisticka shema koja obuhvaca sve eksperi-
mentalne rezultate. Ukratko se diskutira o mogueoj vezi izmedu elektrociklicke rav-
noteze, pretpostavljene za N(4)-protonirane 1,4-benzodiazepine, kao zajednicke osobine 
vise slicnih struktura i mehanizma bioloskog djelovanja na centralni nervni sustav. 
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